Firefly Neuroscience (AIFF) Gross Margin (2010 - 2026)

Firefly Neuroscience's Gross Margin history runs 16 years deep, the most recent figure standing at 45.57% for Q1 2026.

• On a quarterly basis, Gross Margin fell 5443.0% year-over-year to 45.57% in Q1 2026; TTM through Mar 2026 was 51.96%, a 56869.0% decrease from a year earlier, with the FY2025 full-year figure at 56.48%, down 4352.0% from the prior year.
• Gross Margin rose to 45.57% in Q1 2026 per AIFF's latest filing, from 44.17% in the prior quarter.
• Across five years, Gross Margin topped out at 5827.15% in Q1 2024 and bottomed at 125.82% in Q4 2023.
• The 5-year median for Gross Margin is 40.9% (2025), against an average of 576.05%.
• Across the five-year window, Gross Margin surged 579674 bps in 2024 and tumbled 572715 bps in 2025, its largest moves.
• Year by year, Gross Margin stood at 26.59% in 2022, then sank by 573 bps to 125.82% in 2023, then surged by 179 bps to 100.0% in 2024, then tumbled by 56 bps to 44.17% in 2025, then increased by 3 bps to 45.57% in 2026.
• Per Business Quant, the three latest AIFF Gross Margin figures stand at 45.57% (Q1 2026), 44.17% (Q4 2025), and 37.63% (Q3 2025).